Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Status:
Active, not recruiting
Trial end date:
2031-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a three method risk adapted design using induction
chemotherapy, transoral surgery and radiation chemotherapy will lessen toxic effects and make
treatment of squamous cell carcinoma of the head and neck (SCCHN) better.